First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples